# Stellate Ganglion Block to Treat Long COVID 19 Case Series

> **NCT05812209** · — · COMPLETED · sponsor: **Metamorphosis LTD** · enrollment: 41 (actual)

## Conditions studied

- Long COVID
- Long Covid19
- Post-COVID-19 Syndrome
- Post Acute COVID-19 Syndrome
- Dysautonomia
- Anosmia
- Dysgeusia
- Brain Fog
- Muscle Pain
- Shortness of Breath
- Dizziness
- Fatigue Post Viral
- Cough
- Menstrual Cycle Abnormal
- Pain

## Interventions

- **PROCEDURE:** Stellate Ganglion Block

## Key facts

- **NCT ID:** NCT05812209
- **Lead sponsor:** Metamorphosis LTD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2023-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05812209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05812209, "Stellate Ganglion Block to Treat Long COVID 19 Case Series". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05812209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*